SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-116804
Filing Date
2022-11-10
Accepted
2022-11-10 07:26:19
Documents
18
Period of Report
2022-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2230152d1_8k.htm   iXBRL 8-K 34736
2 EXHIBIT 1.1 tm2230152d1_ex1-1.htm EX-1.1 255151
3 EXHIBIT 4.1 tm2230152d1_ex4-1.htm EX-4.1 100963
4 EXHIBIT 5.1 tm2230152d1_ex5-1.htm EX-5.1 12168
5 EXHIBIT 99.1 tm2230152d1_ex99-1.htm EX-99.1 10047
6 EXHIBIT 99.2 tm2230152d1_ex99-2.htm EX-99.2 10557
10 GRAPHIC tm2230152d1_ex5-1img01.jpg GRAPHIC 4156
  Complete submission text file 0001104659-22-116804.txt   704682

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mrns-20221107.xsd EX-101.SCH 3048
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrns-20221107_lab.xml EX-101.LAB 34476
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrns-20221107_pre.xml EX-101.PRE 22605
12 EXTRACTED XBRL INSTANCE DOCUMENT tm2230152d1_8k_htm.xml XML 3739
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 221374940
SIC: 2834 Pharmaceutical Preparations